First Metatarsophalangeal Joint Arthritis: Comprehensive Review of Conservative and Surgical Treatment Options

Introduction

Arthritis of the first metatarsophalangeal (MTP) joint, commonly referred to as hallux rigidus when stiffness predominates, is a progressive degenerative condition affecting the articulation between the first metatarsal head and the proximal phalanx of the hallux. It is the most common arthritic condition of the foot and represents the second most common pathology of the first MTP joint after hallux valgus. The condition can significantly impair gait, athletic performance, occupational function, and overall quality of life.

First MTP joint arthritis is characterized by progressive degeneration of the articular cartilage, osteophyte formation, joint space narrowing, pain, and loss of motion. Dorsiflexion is typically affected first, resulting in altered gait mechanics and compensatory loading patterns throughout the foot and lower extremity.

The etiology of first MTP arthritis is multifactorial and may include repetitive microtrauma, prior injury, anatomical predisposition, inflammatory arthropathy, osteochondral lesions, biomechanical abnormalities, and genetic factors. The condition affects both active and sedentary populations and may present across a broad age range.

This article provides a comprehensive review of first MTP joint arthritis, including clinical presentation, diagnosis, conservative management strategies, and the full spectrum of surgical treatment options.

Anatomy and Biomechanics

The first MTP joint is a synovial hinge joint formed by the articulation of the first metatarsal head and the base of the proximal phalanx. The sesamoid apparatus beneath the first metatarsal head plays a critical role in load distribution and mechanical efficiency during gait.

Normal first MTP joint motion includes approximately:

• 65–75 degrees of dorsiflexion

• 15–30 degrees of plantarflexion

During the propulsive phase of gait, the first MTP joint experiences substantial forces, often exceeding body weight multiple times. Progressive cartilage degeneration and dorsal osteophyte formation restrict dorsiflexion, leading to compensatory gait changes such as lateral weight transfer, early heel rise, and increased forefoot loading.

Etiology and Risk Factors

Primary Osteoarthritis

Primary degenerative arthritis develops gradually without a clearly identifiable inciting event and may be related to repetitive stress and genetic predisposition.

Post-Traumatic Arthritis

Prior injury is a common cause and may include:

• Turf toe injuries

• Intra-articular fractures

• Sesamoid injuries

• Repetitive microtrauma

• Osteochondral defects

Anatomical and Biomechanical Factors

Several structural abnormalities may predispose patients to first MTP degeneration:

• Long first metatarsal

• Metatarsus primus elevatus

• Flat or chevron-shaped joint morphology

• Hypermobile first ray

• Hallux valgus interphalangeus

• Pes planus or cavus deformity

Inflammatory Arthropathy

Inflammatory conditions that may affect the first MTP joint include:

• Rheumatoid arthritis

• Psoriatic arthritis

• Gout

• Seronegative spondyloarthropathies

Clinical Presentation

Patients commonly present with:

• Pain localized to the dorsal or dorsomedial first MTP joint

• Pain during push-off and walking

• Progressive stiffness

• Difficulty with stairs, running, or squatting

• Swelling

• Shoe irritation from dorsal osteophytes

• Reduced athletic tolerance

As disease progresses, patients may alter gait mechanics to avoid painful dorsiflexion.

Physical Examination

Key examination findings include:

• Reduced dorsiflexion

• Dorsal osteophyte prominence

• Pain at terminal dorsiflexion

• Crepitus

• Joint line tenderness

• Swelling and synovitis

• Altered gait mechanics

• Transfer metatarsalgia

Advanced disease may demonstrate near-complete loss of motion and pain throughout the arc of movement.

Conservative Treatment Options

Conservative treatment is generally recommended initially for most patients unless severe deformity or end-stage arthritis is present.

The goals of nonoperative treatment include:

• Pain reduction

• Motion preservation

• Functional improvement

• Reduction of mechanical stress

• Delay or avoidance of surgery

Activity Modification

Activity modification is often a first-line intervention.

Patients may benefit from reducing activities that require repetitive first MTP dorsiflexion, including:

• Running

• Sprinting

• Lunges

• Stair climbing

• High-impact sports

• Deep squatting

Low-impact alternatives include:

• Cycling

• Swimming

• Elliptical training

• Rowing

Footwear Modifications

Proper footwear can substantially reduce symptoms.

Recommended shoe characteristics include:

• Wide toe box

• Stiff sole

• Rocker-bottom sole

• Increased toe spring

• Cushioned forefoot

Avoiding flexible minimalist shoes and high heels may reduce painful joint motion.

Orthotics and Bracing

Orthotic management aims to reduce painful first MTP motion and redistribute plantar pressures.

Custom Orthotics

Custom orthoses may include:

• Morton’s extension

• Carbon fiber foot plates

• Reverse Morton’s extension

• Arch support

• Forefoot posting

Carbon Fiber Plates

Rigid carbon fiber inserts reduce first MTP dorsiflexion during gait and can provide meaningful symptom relief.

Turf Toe Plates

Rigid plates inserted into shoes help limit painful motion during athletic activities.

Physical Therapy

Physical therapy may provide symptom improvement in selected patients.

Potential interventions include:

• Joint mobilization

• Stretching exercises

• Gastrocnemius stretching

• Intrinsic foot strengthening

• Gait retraining

• Manual therapy

• Balance training

Medications

NSAIDs

Nonsteroidal anti-inflammatory drugs may reduce pain and inflammation.

Examples include:

• Ibuprofen

• Naproxen

• Meloxicam

• Celecoxib

Topical Anti-Inflammatories

Topical diclofenac may provide localized symptom relief with reduced systemic exposure.

Acetaminophen

Acetaminophen may assist with pain control in patients unable to tolerate NSAIDs.

Ice and Cryotherapy

Cryotherapy can help reduce inflammation and pain, particularly after activity.

Typical recommendations include:

• Ice application for 15–20 minutes

• Several times daily as needed

Injections

Corticosteroid Injections

Intra-articular corticosteroid injections may provide temporary symptom relief.

Benefits include:

• Reduction in inflammation

• Short-term pain improvement

• Diagnostic value

Limitations include:

• Temporary duration

• Potential cartilage toxicity with repeated injections

• Risk of flare reaction or infection

Platelet-Rich Plasma (PRP)

PRP injections are increasingly utilized, though evidence remains mixed. Potential benefits include reduction in inflammation and symptom improvement.

Biologic and Regenerative Therapies

Additional investigational treatments include:

• Bone marrow aspirate concentrate (BMAC)

• Stem cell therapies

• Amniotic-derived products

Long-term evidence remains limited.

Surgical Treatment Options

Surgical intervention is considered when conservative management fails to adequately relieve symptoms or when significant structural degeneration is present.

Surgical decision-making depends on:

• Severity of arthritis

• Patient age

• Activity level

• Functional goals

• Motion preservation desires

• Bone quality

• Presence of deformity

Surgical procedures range from joint-preserving techniques to definitive fusion.